SHR1701
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SHR1701, covering 2020-09-23 to 2025-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer [Phase 3]